Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
ADVL1722: A Phase 2, Multicenter, Open- Label Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Subjects with Relapsed/Refractory
Grant
Overview
Affiliation
Overview
Date/time Interval
February 26, 2018 - February 25, 2022
Awarded By
CHILDREN'S HOSPITAL (PHILADELPHIA)
Total Award Amount
22900.00
Direct Costs
16838.00
Sponsor Award Id
Affiliation
Contributor
Ana Galtarossa Xavier
Investigator
Elizabeth Alva
Investigator
Emily Johnston
Investigator
Gregory Friedman M.D.
Principal Investigator
Jamie Aye
Investigator
Kimberly Whelan M.D.
Investigator
Laura Metrock
Investigator
Matthew Kutny M.D.
Investigator
Wayne Liang
Investigator